Jet lag, also called jet lag disorder, is a temporary sleep problem that can affect anyone who quickly travels across multiple time zones. Jet lag can cause daytime fatigue, an unwell feeling, difficulty staying alert and gastrointestinal problems. Jet lag is temporary, but it can significantly reduce vacation or business travel comfort. Jet lag does not usually require treatment. Symptoms often improve within a few days, though they sometimes last longer. However, if you're a frequent traveler continually bothered by jet lag, your doctor may prescribe medications.
This report contains market size and forecasts of Desynchronosis Treatment in global, including the following market information:
Global Desynchronosis Treatment Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Desynchronosis Treatment Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Desynchronosis Treatment companies in 2021 (%)
The global Desynchronosis Treatment market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Prescription Drugs Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Desynchronosis Treatment include Teva, Mylan, Nature’s Bounty, Otsuka Pharma (Pharmavite), Boiron, Miers Laboratories, Genexa, Homeocan and Clinigen Group and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Desynchronosis Treatment manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Desynchronosis Treatment Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Desynchronosis Treatment Market Segment Percentages, by Type, 2021 (%)
Prescription Drugs
OTC
Global Desynchronosis Treatment Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Desynchronosis Treatment Market Segment Percentages, by Application, 2021 (%)
Hospital Pharmacies
Retail Pharmacies
Online
Global Desynchronosis Treatment Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Desynchronosis Treatment Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Desynchronosis Treatment revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Desynchronosis Treatment revenues share in global market, 2021 (%)
Key companies Desynchronosis Treatment sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Desynchronosis Treatment sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Teva
Mylan
Nature’s Bounty
Otsuka Pharma (Pharmavite)
Boiron
Miers Laboratories
Genexa
Homeocan
Clinigen Group
Vanda Pharma